A scDb-based trivalent bispecific antibody for T-cell-mediated killing of HER3-expressing cancer cells

Abstract HER3 is a member of the EGF receptor family and elevated expression is associated with cancer progression and therapy resistance. HER3-specific T-cell engagers might be a suitable treatment option to circumvent the limited efficacy observed for HER3-blocking antibodies in clinical trials. I...

Full description

Saved in:
Bibliographic Details
Main Authors: Nadine Aschmoneit, Sophia Steinlein, Lennart Kühl, Oliver Seifert, Roland E. Kontermann
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/d989d218664f4b1999818ee6967f204d
Tags: Add Tag
No Tags, Be the first to tag this record!